Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Organovo Holdings Inc (NASDAQ:ONVO)

3.10
Delayed Data
As of 3:59pm ET
 +0.16 / +5.44%
Today’s Change
1.60
Today|||52-Week Range
4.99
+24.50%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$305.4M

Company Description

Organovo Holdings, Inc. is a biotechnology company, which designs and creates functional and three-dimensional human tissues for medical research and therapeutic applications. It also develops and commercializes a platform technology for the generation of three-dimensional human tissues that can be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company collaborates with pharmaceutical and academic partners to develop human biological disease models in three dimensions. Organovo Holdings was founded on January 30, 2012 and is headquartered in San Diego, CA.

Contact Information

Organovo Holdings, Inc.
6275 Nancy Ridge Drive
San Diego California 92121
P:(858) 224-1000
Investor Relations:
(858) 224-1092

Employees

Shareholders

Mutual fund holders9.09%
Individual stakeholders16.53%
Other institutional10.27%

Top Executives

Keith MurphyChairman, President & Chief Executive Officer
Craig S. KussmanChief Financial Officer
Sharon Collins PresnellChief Scientific Officer
Jennifer BushSecretary, General Counsel & Compliance Officer
Jennifer Kinsbruner BushSecretary, General Counsel & Compliance Officer